{"id":"F2007B00184","name":"Financial Management and Accountability Act 1997 - Determination to Establish Component of the Reserved Money Fund (PBPA - Factor (f) Funds Reserve) (07/04/1998)","slug":"f2007b00184","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":325121,"registerId":"commonwealth-F2007B00184-current","compilationNumber":null,"startDate":"2026-04-08","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Financial Management and Accountability Act 1997 - Determination to Establish Component of the Reserved Money Fund (PBPA - Factor (f) Funds Reserve) (07/04/1998)","content":"SECTION 20 OF THE FINANCIAL MANAGEMENT AND ACCOUNTABILITY ACT 1997\n\nDETERMINATION TO ESTABLISH COMPONENT OF THE RESERVED MONEY FUND\n\nI, Graham Millar, Branch Manager, Financial Framework, pursuant to powers delegated to me by the Finance Chief Executive under section 53 of the Financial Management and Accountability Act 1997, determine, for the purposes of section 20 of that Act, that the Department of Health and Family Services – PBPA – Factor (f) Funds Reserve is established as a component of the Reserved Money Fund.\n\nI further determine that:\n\n(a) amounts of the following kinds may be transferred from the Consolidated Revenue Fund to this component:\n\n-   all money appropriated by law for the purpose of payment into the component;\n-   all money received in consideration for any service, benefit, activity, transaction or other matter which is congruent with the expenditure purposes of the component;\n-   all money paid to the Commonwealth by any person for the expenditure purposes of the component; and,\n\n(b) the purposes for which amounts may be debited to the component are:\n\n-   for expenditure in relation to the Factor (f) scheme, part of the Pharmaceutical Industry Development Program, to facilitate increases in manufacture, research and product and process development in Australia.\n\nGraham Millar\n\nDelegate of the Finance Chief Executive\n\n7/4/98","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1862},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This determination performs exactly the narrow administrative function described: it establishes a specific reserve fund for the Factor (f) pharmaceutical pricing scheme. There is no expansion beyond this single accounting mechanism."},"complexity_factors":["Very short instrument with only two operative subsections (a) and (b)","No definitions section - assumes reader knows external acronyms 'PBPA' and 'Factor (f)'","Minimal cross-referencing (only to FMA Act 1997 sections 20 and 53)","Simple binary logic: specified money in, specified purpose out"],"plain_english_summary":"This determination creates a dedicated reserve—the \"PBPA – Factor (f) Funds Reserve\"—within the Commonwealth’s accounts to hold and manage monies for a pharmaceutical industry support program. Funded by parliamentary appropriations and program receipts, the reserve finances the Factor (f) scheme under the Pharmaceutical Industry Development Program to encourage domestic manufacturing, research and product development. It mainly affects the Department of Health and participating pharmaceutical companies."}},"importantCases":[],"_links":{"self":"/api/acts/f2007b00184","history":"/api/acts/f2007b00184/history","analysis":"/api/acts/f2007b00184/analysis","conflicts":"/api/acts/f2007b00184/conflicts","importantCases":"/api/acts/f2007b00184/important-cases","documents":"/api/acts/f2007b00184/documents"}}